DURHAM, NC -- (MARKET WIRE) -- May 16, 2007 -- Aldagen, Inc., a biotechnology company advancing a pipeline of clinical-stage regenerative therapies, today announced that Matthew E. Czajkowski will serve as Chief Financial Officer. Matt brings more than 25 years of financial management expertise with both private and public companies and within the banking industry.
